Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

SFOSF Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.42B CNY in the quarter ending March 31, 2025, a decrease of -7.26%. This brings the company's revenue in the last twelve months to 40.33B, down -0.87% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

• Revenue (ttm): 40.33B CNY
• Revenue Growth: -0.87%
• P/S Ratio: 1.52
• Revenue / Employee: 994.41K CNY
• Employees: 40,557
• Market Cap: 8.47B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.07B	-332.34M	-0.80%
Dec 31, 2023	41.40B	-2.55B	-5.81%
Dec 31, 2022	43.95B	4.94B	12.66%
Dec 31, 2021	39.01B	8.70B	28.72%
Dec 31, 2020	30.31B	1.72B	6.02%